ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma

NASuspendedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions

Glioma

Interventions

DEVICE

ExAblate 4000 - Type 2

Using ExAblate Model 4000 Type-2 to temporarily disrupt the blood brain barrier in non-enhancing suspected infiltrating glioma undergoing resection

Trial Locations (1)

University of Maryland Medical System, Baltimore